AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders-Reference-Cited by-同舟云学术

AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders

Published:2010-04 Issue: Volume: Page:no-no
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Dawson Mark A.,Curry Jayne E.,Barber Kelly,Beer Philip A.,Graham Brent,Lyons John F.,Richardson Caroline J.,Scott Mike A.,Smyth Tomoko,Squires Matthew S.,Thompson Neil T.,Green Anthony R.,Wallis Nicola G.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2010.08175.x/fullpdf

Reference46 articles.

1. Polycythemia vera: stem-cell and probable clonal origin of the disease;Adamson;New England Journal of Medicine,1976

2. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta;Apperley;The New England Journal of Medicine,2002

3. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders;Baxter;Lancet,2005

4. MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort;Beer;Blood,2008

5. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down’s syndrome;Bercovich;Lancet,2008

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposed AT9283 triggers anti-tumoral effects by targeting MKK3 oncogenic functions in Colorectal Cancer;Journal of Experimental & Clinical Cancer Research;2024-08-20

2. The Goldilocks paradigm: comparing classical machine learning, large language models, and few-shot learning for drug discovery applications;Communications Chemistry;2024-06-12

3. Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer;Molecular and Cellular Biochemistry;2024-03-22

4. Regulation of Cell Cycle Progression through RB Phosphorylation by Nilotinib and AT-9283 in Human Melanoma A375P Cells;International Journal of Molecular Sciences;2024-03-03

5. DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target;Journal of Translational Medicine;2024-02-27